Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Toronto

$165,000.00

Opioid Agonist Therapy Amidst the Overdose Crisis and the Novel Coronavirus (COVID-19) Pandemic: Attitudes and Access

FY 2020-21

Summary
Thousands of Canadians continue to die each year from the overdose crisis, which is largely caused by the presence of fentanyl in the street drug supply. The COVID-19 pandemic has further worsened the overdose crisis, with rates of overdose deaths increasing since the pandemic began. As a result, people who use opioids (PWUO) are now facing two life-threatening crises. The primary medical treatment used to help people stop using non-prescribed opioids is medication, also referred to as opioid agonist therapy (OAT), to help reduce cravings and prevent overdose. However, some PWUO have difficulty accessing or prefer not to use these medications. This may be due to the requirements to attend frequent doctor visits, lack of clinics, or not liking the medications themselves due to side effects or other reasons. It is important to get the opinion of PWUO as to why some are choosing not to use or stay on OAT; however, those opinions are often neglected by researchers. This fellowship project aims to incorporate the views and preferences of PWUO to examine three important aspects of how the overdose crisis and COVID-19 may be impacting medication treatment. First, we will use data collected from a large group of PWUO to analyze whether fentanyl use is associated with lower satisfaction for methadone, the most commonly used form of OAT. Second, we will ask PWUO to make choices between different aspects of medication treatment and use that information to determine what is preferred; this research method is called a discrete choice experiment. Finally, we will use a large Ontario-based database to see how the COVID-19 pandemic is impacting access to OAT. The results of this study will be used to decide how to best provide medications for opioid use in order to reduce overdose death and improve care for PWUO during the overdose crisis, COVID-19 pandemic, and beyond.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
441137
Name
Young Samantha V
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Research Training B - HP
Projecttitle
Opioid Agonist Therapy Amidst the Overdose Crisis and the Novel Coronavirus (COVID-19) Pandemic: Attitudes and Access
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$165,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Community Engagement; Covid-19; Discrete Choice Experiment; Epidemiology; Harm Reduction; Health Services Research; Observational Cohort Study; Opioids; Overdose; Substance Use
Abstract
Thousands of Canadians continue to die each year from the overdose crisis, which is largely caused by the presence of fentanyl in the street drug supply. The COVID-19 pandemic has further worsened the overdose crisis, with rates of overdose deaths increasing since the pandemic began. As a result, people who use opioids (PWUO) are now facing two life-threatening crises. The primary medical treatment used to help people stop using non-prescribed opioids is medication, also referred to as opioid agonist therapy (OAT), to help reduce cravings and prevent overdose. However, some PWUO have difficulty accessing or prefer not to use these medications. This may be due to the requirements to attend frequent doctor visits, lack of clinics, or not liking the medications themselves due to side effects or other reasons. It is important to get the opinion of PWUO as to why some are choosing not to use or stay on OAT; however, those opinions are often neglected by researchers. This fellowship project aims to incorporate the views and preferences of PWUO to examine three important aspects of how the overdose crisis and COVID-19 may be impacting medication treatment. First, we will use data collected from a large group of PWUO to analyze whether fentanyl use is associated with lower satisfaction for methadone, the most commonly used form of OAT. Second, we will ask PWUO to make choices between different aspects of medication treatment and use that information to determine what is preferred; this research method is called a discrete choice experiment. Finally, we will use a large Ontario-based database to see how the COVID-19 pandemic is impacting access to OAT. The results of this study will be used to decide how to best provide medications for opioid use in order to reduce overdose death and improve care for PWUO during the overdose crisis, COVID-19 pandemic, and beyond.
Competitiondate
202012
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Young, Samantha V
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $165,000~ $0~
University of Toronto - $165,000 Grant (2020-21) | Canada Spends